Novavax, Inc.: Revision history

20 August 2022

• curprev 10:3910:39, 20 August 2022 95.149.241.133 talk 1,015 bytes +11 No edit summary undo

13 August 2022

• curprev 15:4115:41, 13 August 2022 109.180.50.163 talk 1,004 bytes +15 No edit summary undo

30 July 2022

• curprev 15:3415:34, 30 July 2022 >Chris 989 bytes +989 Created page with "Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respirat..."